Stenting or Surgery for De Novo Common Femoral Artery Stenosis

التفاصيل البيبلوغرافية
العنوان: Stenting or Surgery for De Novo Common Femoral Artery Stenosis
المؤلفون: Eric Ducasse, Jean-Marc Alsac, Eugenio Rosset, Bahaa Nasr, Yann Gouëffic, Thierry Reix, Nellie Della Schiava, Jean-Pierre Favre, Béatrice Guyomarch, Eric Allaire, Fabien Thaveau, Raphael Soler, Réda Hassen-Khodja, Lucie Salomon du Mont
المصدر: JACC. Cardiovascular interventions. 10(13)
سنة النشر: 2017
مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Femoral artery, Constriction, Pathologic, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Asymptomatic, 03 medical and health sciences, 0302 clinical medicine, Postoperative Complications, Restenosis, Interquartile range, medicine.artery, medicine, Humans, 030212 general & internal medicine, Prospective Studies, Vascular Patency, Aged, Peripheral Vascular Diseases, business.industry, Mortality rate, Endovascular Procedures, Perioperative, Length of Stay, Middle Aged, medicine.disease, Thrombosis, Surgery, Femoral Artery, Stenosis, Treatment Outcome, Female, Stents, France, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Vascular Surgical Procedures
الوصف: The TECCO (Traitement des Lésions Athéromateuses de l'Artère Fémorale Commune par Technique Endovasculaire Versus Chirurgie Ouverte [Endovascular Versus Open Repair of the Common Femoral Artery]) trial is a randomized comparison of safety and efficacy of stenting versus open surgery for de novo common femoral artery (CFA) stenosis.Surgery for CFA lesions is considered effective and durable. Despite the widespread use of endovascular repair for infrainguinal disease, the value of this procedure for such lesions is uncertain.From February 23, 2011, to September 5, 2013, a total of 117 patients with de novo atherosclerotic lesions of the CFA were randomly assigned to undergo surgery (n = 61) or stenting (n = 56). The main exclusion criteria were asymptomatic disease, restenosis, and thrombosis of the CFA. The primary outcome was the morbidity and mortality rate within 30 days. This includes any general complications or local complications that caused or prolonged hospitalization and/or re-intervention, lymphorrhea of more than 3 days, and post-operative paresthesia that required drugs. The median duration of follow-up was 2 years (interquartile range [IQR]: 19.8 to 24.9 years).Primary outcome events occurred in 16 of 61 patients (26%) in the surgery group and 7 of 56 patients (12.5%) in the stenting group (odds ratio: 2.5; 95% confidence interval: 0.9 to 6.6; p = 0.05). The mean duration of hospitalization was significantly lower in the stenting group (3.2 ± 2.9 days vs. 6.3 ± 3 days; p 0.0001). At 24 months, the sustained clinical improvement, the primary patency rate, and the target lesion and extremity revascularization rates were not different in the 2 groups.In patients with de novo atherosclerotic lesions of the CFA, the perioperative morbidity and mortality rate was significantly lower among patients who underwent endovascular therapy by stenting compared with surgery, whereas clinical, morphological, and hemodynamic outcomes were comparable at mid-term. (Traitement des Lésions Athéromateuses de l'Artère Fémorale Commune par Technique Endovasculaire Versus Chirurgie Ouverte [Endovascular Versus Open Repair of the Common Femoral Artery] [TECCO]; NCT01353651).
تدمد: 1876-7605
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48ed76ed26d9639bd85bed221547d226
https://pubmed.ncbi.nlm.nih.gov/28683942
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....48ed76ed26d9639bd85bed221547d226
قاعدة البيانات: OpenAIRE